North Pacific Clinical Research

Redmond, Washington 98052

0 studies enrolling now · 2 studies all time

What they study most

Clostridium Infections, Diarrhea, Irritable Bowel Syndrome

Studies at this site

• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) — Completed